Transforming Innovative Research Into Commercial Reality
The Lachesis Fund is an early stage seed fund investing in the technologies arising from research undertaken at the Universities of Derby, De Montfort, Leicester, Lincoln, Loughborough, Northampton, Nottingham and Nottingham Trent.
The Fund Provides venture capital investment to transform innovative research into commercial reality.
Who Can Apply
Any member of staff from our partner Universities who has an idea that they
would like to commercialise.
Investment PortfolioVIEW OUR FULL INVESTMENT PORTFOLIO
31st October 2012 - Haemostatix Ltd, a biopharmaceutical company, announced today that it has received an additional £1.4 million Translation Award from the Wellcome Trust to continue development of its innovative haemostat technology. The funding…
Braveheart Investment Group plc (BRH), the AIM-listed investment management group specialising in venture capital investments and investment services to business angels, high net worth individuals, family offices and public sector organisations, is pleased to…